Literature DB >> 23550500

Rare diseases with oral components: care course and quality of life.

S Toupenay1, N Razanamihaja, A Berdal, M L Boy-Lefèvre.   

Abstract

AIM: To describe links between the care course of individuals suffering from rare diseases and socio-behavioural risk factors and to ascertain the impact of dental conditions on the quality of life.
DESIGN: A cross-sectional comparative study involving self-reported questionnaire was performed. Care course was evaluated using predisposing, enabling and needs factors. The impacts of dental conditions on quality of life were measured with the OHIP 14 questionnaire. Proportions were compared by Chi-square test. Logistic regression for multivariate analysis assessed statistical association between variables.
RESULTS: Responses were received from 355 subjects (mean age 36.9 years, 67.6% females). Thirty-three rare diseases were recorded. Respondents were classified as group A, individuals suffering from rare diseases with a dental component (n=207, 58.3%), and group B, without dental component. Group A reported earlier diagnosis, more positive attitude toward dentists, functional limitation and higher prosthetic treatment needs. Only 17.4% of subjects having fewer than 20 teeth wear prosthetics. A higher percentage of individuals claiming pain, physical disability, psychological discomfort and social disability, was found among group B (p<0.001). Logistic regression analysis retained two impact factors: psychological disability (Exp(B)=8.66; 95% CI 1.86-40.34) and social wellbeing (Exp(B)=0.06; 95% CI 0.02-0.215).
CONCLUSION: Rare diseases with a dental component benefited from earlier identification of symptoms. Dentists could contribute to patients' quality of life by helping in early diagnosis, reducing functional limitation and improving social wellbeing.

Entities:  

Mesh:

Year:  2013        PMID: 23550500

Source DB:  PubMed          Journal:  Community Dent Health        ISSN: 0265-539X            Impact factor:   1.349


  6 in total

1.  Gingival hyperplasia as first sign of recurrence of granulomatosis with polyangiitis (Wegener's granulomatosis): case report and review of the literature.

Authors:  Marcel Hanisch; Leopold F Fröhlich; Johannes Kleinheinz
Journal:  BMC Oral Health       Date:  2016-08-02       Impact factor: 2.757

2.  Oral health related quality of life of children and adolescents affected by rare orofacial diseases: a questionnaire-based cohort study.

Authors:  Lisa Friedlander; Ariane Berdal; Priscilla Boizeau; Brigitte Alliot Licht; Marie-Cécile Manière; Arnaud Picard; Olivier Azzis; Marie-Paule Vazquez; Corinne Alberti; Muriel De La Dure Molla
Journal:  Orphanet J Rare Dis       Date:  2019-06-04       Impact factor: 4.123

3.  Assessing a possible vulnerability to dental caries in individuals with rare genetic diseases that affect the skeletal development.

Authors:  Heloisa Vieira Prado; Natália Cristina Ruy Carneiro; Matheus França Perazzo; Mauro Henrique Nogueira Guimarães de Abreu; Carolina de Castro Martins; Ana Cristina Borges-Oliveira
Journal:  Orphanet J Rare Dis       Date:  2019-06-18       Impact factor: 4.123

4.  [Rare diseases and their clinical oral manifestations in two Hospitals in Yaoundé].

Authors:  Hubert Désiré Mbassi Awa; Rose Mbédé Nga Mvondo; Séraphin Nguefack; Charles Bengondo Messanga; Paul Olivier Koki Ndombo
Journal:  Pan Afr Med J       Date:  2019-04-22

5.  Association between Oral Health-Related Quality of Life in People with Rare Diseases and Their Satisfaction with Dental Care in the Health System of the Federal Republic of Germany.

Authors:  Marcel Hanisch; Sabrina Wiemann; Lauren Bohner; Johannes Kleinheinz; Susanne Jung
Journal:  Int J Environ Res Public Health       Date:  2018-08-13       Impact factor: 3.390

6.  Oral Symptoms and Oral Health-Related Quality of Life in People with Rare Diseases in Germany: A Cross-Sectional Study.

Authors:  Sabrina Wiemann; Nicolas Frenzel Baudisch; Rainer A Jordan; Johannes Kleinheinz; Marcel Hanisch
Journal:  Int J Environ Res Public Health       Date:  2018-07-15       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.